Press Releases

Press Releases

  1. First patient treated with microscopic beads pre-loaded with a targeted cancer drug and visible on CT scans

  2. BTG plc: close period update

  3. BTG plc acquires Roxwood Medical

  4. BTG and Mirada Medical Sign Three-Year Software Development Agreement

  5. BTG plc: legal ruling

  6. Vistogard® and Voraxaze® Added to Revised Guidelines for Stocking of Antidotes in US Hospitals

  7. BTG and SIO expand Immuno-Oncology / Interventional Oncology grant programme

  8. BTG plc: Annual General Meeting

  9. ACCESS PTS Study Demonstrates Efficacy of EKOS® Therapy for Post-Thrombotic Syndrome

  10. New Study Shows Patients Treated With CroFab® Have Improved Recovery From Copperhead Envenomation

  11. New study shows IO Loop™ improves patient follow-up, engagement and satisfaction following treatment with TheraSphere®

  12. SIO announces first grants in Interventional Oncology / Immuno-Oncology research programme

  13. OPTALYSE PE Study Demonstrates Safety and Efficacy of Shorter, Lower Dose EKOS® Therapy For Pulmonary Embolism

  14. BTG and HealthLoop collaborate on IO Loop™, an exclusive service to connect patients and interventional oncologists throughout treatment

  15. BTG plc: Final Results 2017

  16. First European Patients Treated With DC Bead LUMI™ Radiopaque Drug-Eluting Beads

  17. BTG plc: close period update

  18. SnakeBite911™ Expands Free Snake Education and Snakebite Safety App to Android Devices

  19. BTG announces CE Mark Certification for DC Bead LUMI™, the First commercially available Radiopaque Drug-Eluting Bead

  20. BTG Receives U.S. FDA 510(k) Clearance for EKOS® Control Unit 4.0

  21. BTG and Society of Interventional Oncology to explore role of minimally invasive therapies in immuno-oncology

  22. New Varicose Vein Treatment Offers Minimally Invasive Non Surgical Procedure to Canadians

  23. First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® system